Top Suppliers:I want be here

2143072-85-7

2143072-85-7 structure
2143072-85-7 structure
  • Name: RAGE 229
  • Chemical Name: RAGE 229
  • CAS Number: 2143072-85-7
  • Molecular Formula: C23H22N4O2
  • Molecular Weight: 386.45
  • Catalog: Research Areas Metabolic Disease
  • Create Date: 2022-09-25 15:24:58
  • Modify Date: 2025-07-28 13:00:16
  • RAGE 229, N-(4-(7-cyano-4-(morpholin-4ylmethyl) quinolin-2-yl)phenyl)acetamide, is an orally active ctRAGE-DIAPH1 inhibitor. RAGE 229 can inhibit the intracellular RAGE signaling by inhibiting the interaction between the cytoplasmic tail of RAGE(ctRAGE) and Diaphanous-1(DIAPH1)[1].

Name RAGE 229
Description RAGE 229, N-(4-(7-cyano-4-(morpholin-4ylmethyl) quinolin-2-yl)phenyl)acetamide, is an orally active ctRAGE-DIAPH1 inhibitor. RAGE 229 can inhibit the intracellular RAGE signaling by inhibiting the interaction between the cytoplasmic tail of RAGE(ctRAGE) and Diaphanous-1(DIAPH1)[1].
Related Catalog
Target

KD: 2 nM (ctRAGE); IC50: 26 nM (SMC migration)[1]

In Vitro RAGE229 has affinity for the ctRAGE with KDvalue of 2 nM and inhibits SMC migration with an IC50 value of 26 nM[1]. Cell Migration Assay [1] Cell Line: SMCs Concentration: 0.00006 -10 μM. Incubation Time: 1.5 h Result: Inhibited SMC migration with an IC50 value of 26 nM.
In Vivo RAGE229 (oral gavage, 5 mg/kg, twice daily, for 4 days) assuages short- and long-term complications of diabetes in mice. RAGE229 (oral or iv.; 150, 50 and 15 ppm chow; 30, 10, and 3 mg/kg per day per mouse) (5 mg/kg, ip. , every 12 hours for four total doses) reduces plasma concentrations of TNF-α, IL-6, and CCL2/JE-MCP1 in diabetic mice, and reduces pathological and functional indices of diabetes-like kidney disease[1]. Animal Model: female CF-1 mice and male mice with diabetes[1] Dosage: 5 mg/kg Administration: oral gavage, 5 mg/kg, twice daily, for 4 days Result: Reduced inflammation score and infarct area in mice. Animal Model: C57BL/6J mice and BTBR ob/obmice[1] Dosage: 30, 10, and 3 mg/kg; 5 mg/kg Administration: oral or iv.; 150, 50 and 15 ppm chow; 30, 10, and 3 mg/kg per day per mouse; 5 mg/kg, ip., every 12 hours for four total doses Result: Reduced the concentrations of CCL2, TNF-α and IL-6.
References

[1]. Michaele B Manigrasso, et al. Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice. Sci Transl Med. 2021 Nov 24;13(621):eabf7084.

Molecular Formula C23H22N4O2
Molecular Weight 386.45
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.